VTRS
Viatris Inc.
$9.53
Earnings Summary
Revenue | $2961.7Mn |
Net Profits | $189.8Mn |
Net Profit Margins | 6.41% |
Highlights
Viatris Inc.’s revenue jumped 3.47% since last year same period to $2961.7Mn in the Q3 2019. On a quarterly growth basis, Viatris Inc. has generated 3.86% jump in its revenue since last 3-months.
Viatris Inc.’s net profit jumped 7.41% since last year same period to $189.8Mn in the Q3 2019. On a quarterly growth basis, Viatris Inc. has generated 212.64% jump in its net profits since last 3-months.
Viatris Inc.’s net profit margin jumped 3.81% since last year same period to 6.41% in the Q3 2019. On a quarterly growth basis, Viatris Inc. has generated 208.45% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Viatris Inc. post its latest quarter earnings
EPS Estimate Current Quarter | 0.72 |
EPS Estimate Current Year | 0.72 |
Highlights
Viatris Inc.’s earning per share (EPS) estimates for the current quarter stand at 0.72 - a -14.29% fall from last quarter’s estimates.
Viatris Inc.’s earning per share (EPS) estimates for the current year stand at 0.72.
Key Ratios
Key ratios of the Viatris Inc. post its Q4 2022 earnings
Return on Assets (ROA) | 0.03 |
Return on Equity (ROE) | 0.1 |
Dividend Per Share (DPS) | 0.12 |
Highlights
Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Viatris Inc.’s return on assets (ROA) stands at 0.03.
The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Viatris Inc.’s return on equity (ROE) stands at 0.1.
Viatris Inc. declared 0.12 dividend per share during the earnings announcement for Q4 2022.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2021-08-09 | 0.87 | 0.98 | 12.64% |
2021-05-10 | 0.8 | 0.92 | 15% |
2022-02-28 | 0.83 | 0.8 | -3.61% |
2021-11-08 | 0.88 | 0.99 | 12.5% |
Company Information
Viatris Inc. is a new kind of healthcare company, empowering people worldwide to live healthier at every stage of life. It provides access to medicines, advance sustainable operations, develop innovative solutions and leverage its collective expertise to connect more people to more products and services through its one-of-a-kind Global Healthcare GatewayTM. Formed in November 2020through the combination of Mylan and Pfizer's Upjohn business, Viatris brings together scientific, manufacturing and distribution expertise with proven regulatory, medical and commercial capabilities to deliver high-quality medicines to patients in more than 165 countries and territories. Viatris' portfolio comprises more than 1,400 approved molecules across a wide range of therapeutic areas, spanning both non-communicable and infectious diseases, including globally recognized brands, complex generic and branded medicines, a growing portfolio of biosimilars and a variety of over-the-counter consumer products. With a global workforce of approximately 45,000, Viatris is headquartered in the U.S., with global centers in Pittsburgh, Shanghaiand Hyderabad, India.
Organisation | Viatris Inc. |
Headquarters | 1000 Mylan Boulevard, Canonsburg, PA, United States, 15317 |
Employees | 37000 |
Industry | Health Technology |
CEO | Michael Goettler |
